Background Mammography screening can reduce breast cancer mortality. However, most women are unaware that inconsequential disease can also be detected by screening, leading to overdiagnosis and overtreatment. We aimed to investigate whether including information about overdetection of breast cancer in a decision aid would help women aged around 50 years to make an informed choice about breast screening.
Introduction
Mammography screening can reduce a woman's risk of dying from breast cancer but entails the risk of having a cancer diagnosed and treated that would not have presented clinically in her lifetime-termed overdetection or overdiagnosis. Such a diagnosis, and the resulting overtreatment, can harm women physically and emotionally, 1 for example, via increased risk of ischaemic heart disease after radiotherapy 2 or the psychosocial outcomes of labelling.
individual should facilitate decision making that incorporates personal values and preferences, irrespective of whether the eventual choice is to screen or not. 10 In turn, key performance indicators for screening should refl ect informed choice rather than participation. 9, 11, 12 Despite calls for better information about overdetection of disease for women invited to breast screening, few studies have reported public responses to this issue. In qualitative studies, women who were eligible for screening were unaware of overdetection but could understand the idea, placed value on information, and thought that making an informed decision was important. 13, 14 As far as we know, no randomised trial has addressed whether information about overdetection can improve the quality of women's decisions about undergoing breast screening.
Decision aids communicate evidence-based information on benefi ts and harms of diff erent health-care options to help people make informed decisions. Findings of randomised trials show that decision aids improve knowledge and facilitate informed choice in various settings, 15 including cancer screening. 16, 17 In breast screening, however, decision aids have not addressed overdetection comprehensively. In one study, 16 a mammography decision aid was assessed in which information about overdetection was placed in an appendix, the frequency of overdetection was not stated, and the decision aid was designed for 70-year-old women deciding whether to continue screening. High-quality evidence is needed to show how information about the concept and frequency of overdetection aff ects decision making in women approaching age 50 years (when screening is initiated in many countries).
We developed two versions of a decision aid (intervention and control) giving explanatory and quantitative information about important breast-screening outcomes (panel 1). 18 Both versions included information about breast cancer deaths averted and false positives from screening, whereas the intervention decision aid also contained data for overdetection. Levels of benefi t and overdetection were derived from a meta-analysis of screening trials by the Independent UK Panel on Breast Cancer Screening. 6 Although diverse estimates of overdetection are available, derived from various data and methods, randomised trials provide the best evidence for the extent of overdetection. 6, 8 Our resources were designed to support women to make informed choices, not to push them towards or away from screening. 7 Decision aids are provided in situations with no obviously right or wrong option, so the focus in evaluating them should not be on the option selected 23 but rather on decision quality, defi ned in terms of knowledge and agreement between values and choice. 24 Screening rates might not refl ect people's informed decisions if coercion or obstacles are present. 12 The aim of our study was to investigate whether evidencebased consumer-friendly information on over detection improves the level of informed choice about screening in
Panel 1: Intervention and control decision aids
In preparation for our trial we developed a decision aid (the intervention; appendix pp [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , then produced a control version for comparison (appendix pp [15] [16] [17] [18] [19] [20] [21] [22] . 18 The intervention decision aid contained evidence-based information about important outcomes of breast screening over the past 20 years, compared with no screening-ie, breast cancer mortality reduction, overdetection, and false positives. The control version omitted all content about overdetection but was otherwise identical to the intervention decision aid.
Quantitative evidence included in the decision aids was taken from an updated version of a published model of mammography screening outcomes for women in Australia. 19 The model incorporates estimates of both overdetection and the reduction in breast cancer mortality from screening, which were derived from a meta-analysis of randomised trial data 6 and adjusted to account for the eff ect of regularly undergoing screening (not merely receiving an invitation). 20 These estimates were applied to current Australian data for incidence and mortality to quantify cumulative outcomes of biennial screening from age 50-69 years versus no screening over this period. The 20-year cumulative likelihood of a false-positive result (including total women with a false positive and the number of people having a biopsy) was modelled from current Australian data.
This information was presented in a short booklet for women, combining text and visual formats. The expected frequencies of outcomes were illustrated with icon arrays depicting the absolute numbers aff ected per 1000 women screened over 20 years from age 50 years. 21, 22 Content and presentation of the decision aids was guided by our previous qualitative study. 13 We developed and revised the materials based on input from lay-person collaborators and independent experts and after a thorough piloting process. 419 completed follow-up interview 409 answered all relevant questions on the follow-up interview and were analysed for primary outcome 10 did not answer all questions on attitudes and were excluded a community sample of women around the target age for starting breast screening in Australia.
Methods

Study design and participants
We did a community-based parallel-group, randomised controlled trial in New South Wales (NSW), Australia. The NSW Electoral Commission extracted from the electoral register a random cohort of women aged 48-50 years. Trained interviewers from an independent non-profi t company telephoned potential respondents to ascertain their eligibility. Exclusion criteria were: mammography in the past 2 years; a personal history of breast cancer; increased risk of breast cancer compared with the population (eg, strong family history); 25 or insuffi cient spoken English or reading ability to complete telephone interviews and understand study materials. 26 Interviewers described the study to eligible women (they used the term "breast screening information" without mentioning overdetection) and recorded oral consent.
The University of Sydney human research ethics committee approved the trial (2012/1429). The published protocol describes the design, which includes a qualitative substudy that we will present separately.
26
Randomisation and masking
A programmer who had no contact with participants generated the randomisation sequence using a computer system that was inaccessible until after recruitment; therefore, interviewers were unaware of the materials that women would receive (ensuring allocation concealment). We assigned participants to either the intervention or control group in a 1:1 ratio with permuted block sizes of four and eight. Women knew they would receive one of two versions of an information booklet but did not know how these diff ered or which one was the intervention. We designed the follow-up interview to ensure the group assignment was unclear to the interviewer until the fi nal question. Researchers who analysed data were unaware of the random allocation.
Procedures
Panel 1 describes preparation of the intervention and control decision aids, which were presented in the form 
Attitudes towards having breast screening ‡
For you, having breast screening is... Data are number of participants (%), unless otherwise stated. *Informed choice defi ned as adequate knowledge and intentions consistent with attitudes (positive or negative). Participants with missing data for attitudes were excluded from the analysis of informed choice. †Conceptual knowledge subscales were for benefi t, false positives, and overdetection. ‡Attitude items were rated from strongly disagree (1) to strongly agree (5) . Total scores could range from 6 to 30: higher scores indicate more positive attitudes. Data were missing for 21 women. of an information booklet. 18 At recruitment, we sent participants the standard NSW screening programme leafl et, which outlines practical aspects of mammography and describes benefi ts and limitations without giving chances of outcomes nor mentioning overdetection. 27 During a telephone interview 1-4 weeks after recruitment (depending on participant's availability), we obtained baseline demographics, stage of decision making about breast screening, and basic conceptual knowledge, 28 attitudes, 29 and intentions. 30 We then randomised women and sent them their allocated decision aid via the postal system. We gathered outcome data using standardised questions in a structured telephone interview after a further 1-4 weeks (depending on participant's availability). We tested trial procedures in a pilot.
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Outcomes
The primary outcome was informed choice about breast screening, assessed as a dichotomous outcome combining measures of knowledge, attitudes, and intentions. 26 A woman was judged to have made an informed choice if she had adequate knowledge and her attitudes and intentions were consistent (positive attitudes and intentions, or negative attitudes and intentions). Secondary outcomes (eg, decisional confl ict, worry about breast cancer, and opinions about the decision aid) have been detailed in full elsewhere. 26 We assessed conceptual and numerical knowledge with a competency-based approach, 31 drawing on our previous work. 16 We asked questions to assess all participants' understanding of screening outcomes (mortality benefi t, overdetection, and false positives) and awareness of the approximate numbers aff ected (appendix pp [23] [24] . We scored answers with a marking scheme that we developed a priori (appendix p 25). We set a threshold a priori to defi ne adequate knowledge for informed choice: women had to score at least 50% of available marks, including at least one numerical mark, on all three screening outcome subscales.
We measured breast screening attitudes with a validated scale consisting of six items 29 with fi ve response options, forming a scale from six to 30. 17 For informed choice, we set the threshold for a positive attitude at 24. Women indicated their intentions about undergoing breast screening in the next 2-3 years via one item with fi ve responses. For informed choice, we classifi ed "defi nitely will" and "likely to" screen as positive intentions.
This study is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12613001035718.
Statistical analysis
For the primary analysis we compared the proportion of women in the intervention and control groups who made an informed choice. To calculate the sample size, we made a conservative assumption that 50% of women assigned to one of the study groups would make an informed choice. To achieve 80% power (α of 5%, twosided test) to detect a 10% diff erence in informed choice between groups, we needed 407 women per study group at follow-up (in the main quantitative study). Further, we added a subsample of women for the qualitative study and, after allowing for attrition, we aimed to recruit 1078 women.
We did all analyses with SPSS version 22 or Stata version 13. In accordance with our published protocol, 26 we included in our primary analysis all participants as randomised, except for those lost to follow-up and those for whom some outcome data were missing because of incomplete answers to the telephone questionnaire (fi gure). We analysed binary outcomes with the χ² test and continuous outcomes with the two-sample t test (α of 5%, two-sided).
We did two sensitivity analyses to account for missing data. First, for women interviewed at follow-up who did not answer all questions, we imputed values of having a positive attitude. We also did a separate process to impute missing values for women lost to follow-up or who had missing attitude responses. In every analysis, we created 20 imputed datasets using chained equations and we pooled their resulting eff ect measures.
Role of the funding source
The funding source had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data in the study and had fi nal responsibility for the decision to submit for publication. 
Results
From January, 2014, to July, 2014, 2647 women aged 48-50 years were contacted by an independent non-profi t company about the study; of these, 1255 individuals were eligible. 1061 (85%) women gave informed consent and were sent the standard NSW screening programme leafl et. 27 The baseline interview was not completed for 119 women, who were excluded. 942 participants were randomly allocated to receive either the intervention or control decision aid, including 63 women who were chosen at random for the qualitative substudy (fi gure). Of 879 participants in the quantitative stream (440 allocated to the intervention group and 439 assigned the control), 838 (95%) completed the follow-up interview (419 women in each group). Ten women in the intervention group and 11 controls did not provide answers to all attitude questions during the follow-up interview and were excluded from the analysis of the primary outcome. Sociodemographic characteristics were similar for women who did and did not provide follow-up data.
At baseline, participants in both study groups were similar with respect to sociodemographic characteristics, screening intentions, attitudes, and basic conceptual knowledge (table 1) . Screening attitudes at baseline were positive overall; most women (90%) said they defi nitely would or were likely to have breast screening in the next few years. Table 2 presents results for informed choice and its component variables (knowledge, attitudes, and intentions). 99 (24%) of 409 women allocated to the intervention group were judged to have made an informed choice compared with 63 (15%) of 408 women assigned to the control group (diff erence 9%, 95% CI 3-14; p=0·0017). Results for informed choice and its components did not change when missing values were imputed (data not shown).
122 (29%) of 419 women in the intervention group had adequate overall knowledge (ie, achieved the a priori threshold for the three subscales of benefi t, false positives, and overdetection) compared with 71 (17%) of 419 women in the control group (p<0·0001). This diff erence was attributed to better performance of the intervention group on the overdetection subscale (table 2). Table 3 presents group means for knowledge of screening outcomes, by conceptual and numerical subscales. The intervention group had a better understanding of the idea of overdetection and its frequency. Data are number of participants (%), unless otherwise stated. For some variables, data were missing (for a maximum of 23 cases). *Decisional confl ict (low literacy version) on a scale from 0 (no decisional confl ict) to 100 (extreme decisional confl ict). Scores less than 25 are associated with implementing decisions. 32 †Confi dence in decision making, three items rated from 1 (not at all confi dent) to 5 (very confi dent). ‡State trait anxiety inventory (short form), on a scale from 20 to 80, with higher scores indicating greater levels of anxiety. 33 §p value for diff erence in distribution of responses between groups. ¶Consideration of future consequences scale (short form), on a scale from 4 to 20, with higher scores indicating a long-term time perspective (ie, greater orientation towards the future). ||The control decision aid did not mention overdetection, therefore, these questions used the phrase "be(ing) diagnosed and treated for a breast cancer that is not harmful" to refer to overdetection. Attitudes towards breast screening remained positive overall, but they were less positive in the intervention group (table 2) . Mean attitude scores (on a scale of were 24·5 (SD 4·4) in the intervention group and 26·1 (4·1) in controls (p<0·0001), with 282 (69%) of 409 women in the intervention group meeting our threshold for a positive attitude (score of ≥24), compared with 340 (83%) of 408 women in the control group (p<0·0001). Similarly, positive screening intentions prevailed in both groups, but fewer women in the intervention group than in the control group intended to be screened ( No consensus exists on what level of knowledge constitutes being informed. Therefore, we did a sensitivity analysis in which we defi ned adequate knowledge using conceptual items only (appendix p 26). In this analysis, women had to score 100% on conceptual items for benefi t and false positives and 70% on overdetection conceptual items. With these knowledge thresholds, and again combining with attitudes and intentions, an informed choice was made by 203 (50%) of 409 women in the intervention group and 79 (19%) of 408 controls (p<0·0001). Table 4 presents data for secondary outcomes. Mean scores for decisional confl ict did not diff er between the intervention and control groups (12·6 vs 12·2; p=0·78); scores were low overall, with about 50% of women in each study group scoring 0 (no decisional confl ict). 32 Confi dence in decision making was generally high in both groups but, overall, the mean score was signifi cantly lower in the intervention group than in the control group (4·4 vs 4·5; p=0·0003). Anxiety was equivalent between study groups, and slightly lower than the female norm, 33 whereas women in the intervention group were less worried about developing breast cancer than were controls (p=0·0026). With respect to anticipated regret, women in the intervention group were less likely than controls to feel that they might later regret not having breast screening (p=0·0004).
In general, when making a decision about screening, women thought that the chances of each outcome (not only benefi t but also harms) were important to take into account. Participants in each study group were closely similar with respect to perceived risk of breast cancer (both absolute and relative to the average woman) and perceived chances of experiencing the various screening outcomes (eg, overdetection, false positives). Table 5 shows how women used and evaluated the decision aids. In both groups, more than three-quarters of participants judged the booklet to be the right length. Roughly half of each group thought the information presented in the decision aid was completely balanced, whereas more women in the intervention group than controls judged their booklet at least a little slanted away from screening (36% vs 17%). Both decision aids were rated clear and easy to understand, and most women For some variables, data were missing (for a maximum of nine cases). *p value for diff erence in distribution of responses between groups. NSW=New South Wales. found the materials helpful and worth recommending to others. Across groups, about a third of participants had talked with someone (usually their partner or family) about the information in the decision aid. Very few had discussed it with a health-care provider or accessed other sources of breast screening information.
Discussion
Our study fi ndings show that a decision aid containing explanatory and quantitative information on overdetection increased knowledge and enabled more women to make an informed choice about breast screening, compared with a control decision aid with overdetection information omitted. The decision aid did not adversely aff ect women by raising decisional confl ict, anxiety, or worry. Our fi ndings also indicated that some women, when better informed about the balance of harm and benefi t, can make diff erent screening decisions that better align with their values (although most women remained positive towards screening).
Establishing what constitutes an informed choice, and what knowledge is necessary to be informed, is important to this study. We used an expert-led approach that was based on medical guidelines and underpinned by decision theory. 31 We set a stringent a priori threshold requiring women to show numerical and conceptual knowledge. With this method, a fairly low proportion of participants was assessed as informed (24% in the intervention group and 15% in the control group). When we used only conceptual items to defi ne adequate knowledge (including general understanding of overdetection), these proportions were much higher (50% and 19%, respectively). Currently, no consensus exists on precisely what knowledge constitutes being objectively informed for an informed or shared decision. Similar to the idea of informed consent, perspectives vary widely. 34 We have detailed our approach, 31 but little guidance remains on this issue, 35 and this area is an important topic for future research.
Our written resources were designed to be sent via the postal system to homes once only, consistent with current population screening; no additional support was incorporated, such as provider consultation or counselling. The overdetection information was unlikely to have been covered in other screening-related materials available previously to women. About 10% of women in each study group sought information elsewhere (eg, from websites); the study helpline was used rarely. Although the absolute rate of informed choice seems low, we believe the understanding participants showed after reading the short booklet indicates success in communicating information about overdetection and other screening outcomes. Widespread public enthusiasm for cancer screening 36, 37 can cause resistance to information about harms, 38 which have not been well communicated in the past. 39 Mass health education or social marketing campaigns would never rely solely on one small booklet to ensure eff ective communication of new information to the public. We note that the intervention in this trial was compared against a high standard of control information, which was more balanced and informative than most screening programme leafl ets. 7, 39 If the intervention were compared with information typically provided in current practice, we would expect a larger increase in informed choice because the comparison group would have less information than our control group.
The strengths of our study include its randomised design, similar baseline characteristics across groups, and high rates of recruitment and follow-up. Furthermore, an independent non-profi t company recruited women and obtained data. Moreover, a skilled multidisciplinary team developed and iteratively revised the evidence-based intervention, through qualitative research and extensive pilot testing. 18 Also, the primary outcome of our study refl ects international commitments to informed choice as a key quality indicator in screening. 11, 40 Finally, long-term follow-up will monitor psychosocial outcomes and assess how informed choice translates to screening participation, 26 which is of interest for service delivery. Our study is the fi rst randomised trial to investigate the eff ects of providing information about overdetection in 
Systematic review
In 2012, an independent panel from the UK published a review of the evidence base for overdetection in breast screening, concluding that "information should be made available in a transparent and objective way to women invited to screening so that they can make informed decisions". 6 Decision aids have the potential to address this need. 8 In January, 2014, the Cochrane Collaboration published an updated systematic review of randomised trials evaluating decision aids in people making health treatment or screening decisions. 15 The review showed that decision aids are eff ective at improving people's knowledge about their options and facilitating informed choice in a range of clinical contexts. Of the trials identifi ed by the Cochrane search, 15 only two were randomised trials about decision aids in breast cancer screening: a booklet for women aged 70 years considering whether to continue or stop screening; 16 and an online decision aid for women aged 40 years considering whether to start screening early or wait until age 50 years. 28 These two decision aids were targeted to women outside the core recommended age range for screening, and the study designs did not enable assessment of the specifi c eff ect of overdetection information. 16, 28 Allthough both decision aids acknowledged the possibility of overdetection, they explained the concept briefl y, without quantitative estimates, and the explanation was in an optional appendix or via a hyperlink. We searched Medline and PsycINFO for articles published since 2012, up to Dec 31, 2014. Search terms included "decision support", "decision aid", "shared decision making", "informed choice", "informed decision", "mammogra*", "breast cancer screening", and "breast screening". We did not identify any additional studies.
Interpretation
Our study is the fi rst randomised controlled trial to evaluate the eff ects of a decision aid providing comprehensive information about the concept and frequency of overdetection, specifi cally among women just entering the target age range for mammography screening who are facing a real decision. Our results provide important new evidence supporting the inclusion of such information in materials aiming to enable informed choice about breast screening.
the context of individual decision making about breast screening at the recommended starting age (panel 2). Findings of qualitative studies suggested that most women learning of the risk of overdetection felt it was outweighed by screening benefi ts. 13, 14 Some focus group participants, however, were concerned about overdetection and screening in view of the new infor mation, particularly younger women (aged 40-50 years). 13 These qualitative results accord with our trial's fi nding that overdetection information prompted a few women to reconsider screening. Women in the intervention group had less worry about breast cancer than did those in the control group, with no diff erence between groups in perceived risk, which corresponds with our qualitative fi nding 13 that some people believed awareness of overdiagnosis might help women feel less afraid of a breast cancer diagnosis.
In a recent survey, 41 women were given a very brief explanation of the idea and frequency of overdetection, reporting a small immediate reduction in future screening intentions among those aged 25-46 years. However, participants had little time to process the information, and comprehension appeared suboptimum, leading the researchers to suggest that such brief materials might be insuffi cient to achieve full appreciation of the issue. 41 Screening intentions also fell in a small pilot study of a mammography decision aid (including conceptual information on overdetection) for women older than 75 years, but the decision aid has not been evaluated in a randomised trial. 42 In prostate cancer screening, for which the harm of overdetection is well established, decision aids reduced the number of men choosing to screen in a meta-analysis of nine trials. 15 However, the extent to which either fi nding is attributable to overdetection information is not clear.
Our study was designed to investigate whether a decision aid could communicate overdetection information, and to assess its eff ects, under the best possible circumstances. We sent all participants a government screening leafl et covering procedural information. Women were highly engaged with both decision aids: at follow-up, 98% of the sample reported reading the entire booklet. Because of our follow-up interviews, participants might have felt obliged to read study materials, possibly limiting the extent to which fi ndings can be generalised outside a research setting. The trial excluded women reporting mammography in the previous 2 years, who would probably have more positive attitudes towards screening and be less amenable to change than our sample. While refi ning our draft decision aid, we expanded our description of treatment side-eff ects to better convey the implications of overdetection. 18 For clarity, we did not include detailed information on the psychosocial outcomes of screening, workup, and treatment, nor did we cover fi nancial strain and opportunity costs. Understanding and responses to screening information might change over time as awareness of overdetection and other harms grows, and this information might be added to future decision aids. Finally, we acknowledge that women's real-life screening decisions are aff ected by many factors other than information provision.
In conclusion, our fi ndings contribute evidence of the eff ectiveness of decision aids in supporting screening policy that values enabling informed choice rather than maximising uptake. 17 Our study shows that women can incorporate overdetection information into their reasoning about screening, thereby improving the quality of their decisions. Our results underscore the importance of striving to meet the ethical responsibility to adequately inform women and help them make screening decisions according to their informed preferences.
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